Average Co-Inventor Count = 4.94
ph-index = 5
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Wyeth (16 from 1,309 patents)
2. Merck Sharp + Dohme Corp. (13 from 2,405 patents)
3. Cyteir Therapeutics, Inc. (8 from 8 patents)
4. Acurx Pharmaceuticals, LLC (3 from 4 patents)
5. Msd Italia S.r.l. (2 from 7 patents)
6. Tabomedex Biosciences, LLC (2 from 2 patents)
42 patents:
1. 12064419 - Methods of using RAD51 inhibitors for treatment of pancreatic cancer
2. 11932636 - RAD51 inhibitors
3. 11607404 - Combinations of RAD51 and PARP inhibitors
4. 11291655 - RAD51 inhibitors
5. 11247988 - RAD51 inhibitors
6. 11084812 - RAD51 inhibitors
7. 11001592 - DNA polymerase IIIC inhibitors and use thereof
8. 10836772 - DNA polymerase IIIC inhibitors and use thereof
9. 10723741 - DNA polymerase IIIC inhibitors and use thereof
10. 10590122 - RAD51 inhibitors
11. 10562909 - Fused quadracyclic compounds, compositions and uses thereof
12. 10336746 - RAD51 inhibitors
13. 10059718 - Fused quadracyclic compounds, compositions and uses thereof
14. 9914736 - TrKA kinase inhibitors, compositions and methods thereof
15. 9862716 - TRKA kinase inhibitors, compositions and methods thereof